ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

EVLO Evelo Biosciences Inc

0.3165
0.00 (0.00%)
Fuera de horario
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Evelo Biosciences Inc EVLO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.3165 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.3165 0.3165
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/1/202416:30EDGAR2Form 15-12G - Securities registration termination [Section..
26/1/202416:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/1/202416:27EDGAR2Form POS AM - Post-Effective amendments for registration..
26/1/202416:26EDGAR2Form 8-K - Current report
12/12/202306:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/12/202306:42EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202305:04EDGAR2Form 8-K - Current report
01/12/202306:11EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202305:44EDGAR2Form 8-K - Current report
09/11/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202316:24EDGAR2Form 8-K - Current report
17/10/202306:05EDGAR2Form 8-K - Current report
17/10/202306:00GLOBEEvelo Biosciences Announces Top-Line Results From its Phase..
13/9/202319:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202319:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202319:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/202306:43EDGAR2Form 8-K - Current report
17/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
14/8/202307:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:42EDGAR2Form 8-K - Current report
14/8/202306:30GLOBEEvelo Biosciences Announces Second Quarter Financial Results..
10/8/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202319:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202319:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202315:21EDGAR2Form 8-K - Current report
18/7/202306:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
12/7/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/7/202306:55EDGAR2Form 8-K - Current report
12/7/202306:30GLOBEEvelo Biosciences Closes $25.5 Million Private Placement
10/7/202306:36EDGAR2Form 8-K - Current report
10/7/202306:30GLOBEEvelo Biosciences Announces $25.5 Million Private Placement
07/7/202315:06EDGAR2Form 8-K - Current report
29/6/202316:10EDGAR2Form 8-K - Current report
29/6/202308:00GLOBEEvelo Biosciences Announces Reverse Stock Split Effective
16/5/202305:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Su Consulta Reciente

Delayed Upgrade Clock